References
- Dishart MK, Kellum JA. An evaluation of pharmacological strategies for the treatment and prevention of acute renal failure. Adis Int Drugs. 2000;59(1):79–91.
- Albright RC. Acute renal failure a practical update. Mayo Clin Proc. 2001;76:6–74.
- Smith S, Marriott J. Acute renal failure. In: Walker R, Edwards C, eds. Acute Renal Failure: Pathophysiology, Diagnosis, and Management. 3rd ed., Edinburgh: Churchill Livingstone; 2003:229–245.
- Chattopadhyay B. Newborns and gentamicin- how much and how often? J Antimicrob Chemother. 2002;49:13–16.
- Smith CR, Lipsky JJ, Laskin OL, Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med. 1980;302(20):1106–1109.
- Tulkens PM. Experimental studies on nephrotoxicity of aminoglycosides at low doses; mechanisms and perspectives. Am J Med. 1986;80:105–114.
- Dominguez JH, Hale CC, Qulali M. Studies of renal injury. Gentamicin toxicity and expression of basolateral transporters. Am J Physiol. 1996;270:F245–F253.
- Horio M, Fukuhara Y, Orita Y, . Gentamicin inhibits Na+ dependent D-glucose transport in rabbit kidney brush- border membrane vesicles. Biochem Biophys Acta. 1986;858:153–160.
- Takamoto K, Kawada M, Usui T, Ishizuka M, Ikeda D. Inhibitory activity of dome formation in LLC PK1 cells is a selective index of aminoglycoside nephrotoxicity. J Antibiot (Tokyo). 2002;55(6):605–612.
- Branch RA. Prevention of amphotericin B-induced renal impairment: A review on the use of sodium supplementation. Arch Intern Med. 1988;148:2389–2396.
- Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int. 1995;47:927–934.
- Albright RC. Acute renal failure a practical update. Mayo Clin Proc. 2001;76:6–74.
- Evenepoel P. Acute toxic renal failure. Best Pract Res Clin Anesthesiol. 2004;18(1):37–52.
- Humes DH, Weinberg JM, Knauss TC. Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity. Am J Kidney Dis. 1982;2:5–29.
- Tulkens PM. Nephrotoxicity of aminoglycoside antibiotics. Toxicol Lett. 1989;46:107–23.
- Coskun S, Ozge U, Nil UC, Sanem G, Selma B, Mujgan C. Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol Pharma Bull. 2007;30:79–83.
- Meher SK, Chaudhuri SB, Marjit B, Munshi S. Nephroprotective effect of nefroliv in gentamicin-induced nephrotoxicity. Phytomedica. 2001;2(1&2):41–8.
- Baliga R, Ueda N, Walker, PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis. 1997;29:465–77.
- Meister A. Glutathione metabolism and its selective modification. J Biol Chem. 1988; 263(33):17205–8.
- Steiner R. Interpreting the fractional excretion of sodium. Am J Med. 1984;77(4):699–702.
- Sandhya P, Mohandass S, Varalakshmi P. Role of dl-alpha lipoic acid in gentamicin induced nephrotoxicity. Mol Cell Biochem. 1995;145:11–17.
- Tulkens PM. Experimental studies on nephrotoxicity of aminoglycosides at low doses; mechanisms and perspectives. Am J Med. 1986;80:105–14.
- Dominguez JH, Hale CC, Qulali M. Studies of renal injury. Gentamicin toxicity and expression of Basolateral transporters. Am J Physiol. 1996;270:F245–53.
- Horio M, Fukuhara Y, Orita T, . Gentamicin inhibits Na+ dependent D-glucose transport in rabbit kidney brush- border membrane vesicles. Bio Chem Biophys Acta. 1986;858:153–60.
- Takamoto K, Kawada M, Usui T, Ishizuka M, Ikeda D. Inhibitory activity of dome formation in LLC PK1 cells is a selective index of aminoglycoside nephrotoxicity. J Antibiot (Tokyo) 2002;55(6):605–12.
- Branch RA. Prevention of amphotericin B-induced renal impairment: a review on the use of sodium supplementation. Arch Intern Med. 1988;148:2389–96.
- Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int 1995;47:927–34.
- Albright RC. Acute renal failure a practical update. Mayo Clin Proc 2001;76:6–74.
- Evenepoel P. Acute Toxic Renal Failure. Best Pract Res Clin Anesthesiol 2004;18(1):37–52.